Quality & complianceOfficial
Bayer to permanently withdraw Verquvo 2.5 mg tablets from Danish market
🇩🇰 DKMA · Fri 20 Nov 2026
The Danish Medicines Agency says marketing of vericiguat 2.5 mg film-coated tablets by Bayer A/S will end for commercial reasons, from the end of September 2026.
The Danish Medicines Agency (DKMA) has listed Verquvo 2.5 mg film-coated tablets in its supply notifications. Bayer A/S will stop marketing the product in Denmark.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (DKMA). AI-assisted; check the source before acting.
More Quality & compliance
All →
Terumo Aortic recalls all in-date Relay Pro and Treo stent-graft systems over endotoxin risk
🇨🇦 Health Canada · Fri 20 Nov 2026
New Jersey health centre owner jailed for 180 days over billing fraud and unlicensed practice
🇺🇸 HHS OIG · Fri 20 Nov 2026
Richmond couple sentenced over Medicaid mental health billing scheme worth nearly $1m
🇺🇸 HHS OIG · Fri 20 Nov 2026
InnovAge settles Colorado Medicaid false claims allegations over senior care services
🇺🇸 HHS OIG · Fri 20 Nov 2026
Michigan Home Health Agency Owner Gets Four Years in Prison for $1.6m Medicare Fraud
🇺🇸 HHS OIG · Fri 20 Nov 2026
South Carolina arrests 19-year-old provider over Medicaid billing for services never delivered
🇺🇸 HHS OIG · Fri 20 Nov 2026